Tadataka Yamada - Jul 28, 2021 Form 3 Insider Report for Icosavax, Inc. (ICVX)

Role
Director
Signature
/s/ Thomas Russo, Attorney-in Fact
Stock symbol
ICVX
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
3
Date filed
7/28/2021, 09:23 PM
Previous filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ICVX Common Stock 124K Jul 28, 2021 Direct F1
holding ICVX Common Stock 627K Jul 28, 2021 By Leslie D. Yamada 2016 Trust F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 65.7K $1.04 Direct F4
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 481K $5.90 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 64,884 shares subject to repurchase by us, which are subject to vesting.
F2 Includes 53,280 shares subject to repurchase by us, which are subject to vesting.
F3 The securities reported herein may be deemed beneficially owned by Tadataka Yamada, M.D., who is a co-trustees of the Leslie D. Yamada 2016 Trust.
F4 25% of the shares subject to the option will vest on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F5 25% of the shares subject to the option will vest on 3/19/2022, and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney